Dr. Laxman Desa
president and CEO.
surgery
Toxikon Asia, Japan
Japan
Biography
Prior to establishing the company, Dr. Desai managed oncology drug research programs at the Dana-Farber Cancer Institute in Boston. It is through his expertise that Toxikon became established in life sciences and has continued to advance innovations in the pharmaceutical, biotechnology, and medical device industries for more than 30 years.
Research Interest
surgery
